(PVAL) Putnam Focused Large Cap - Ratings and Ratios
Common Stocks, Large-Cap Value, Midsize, U.S.
| Risk via 10d forecast | |
|---|---|
| Volatility | 12.6% |
| Value at Risk 5%th | 21.3% |
| Relative Tail Risk | 2.44% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.53 |
| Alpha | 0.58 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.338 |
| Beta | 0.763 |
| Beta Downside | 0.869 |
| Drawdowns 3y | |
|---|---|
| Max DD | 15.41% |
| Mean DD | 2.34% |
| Median DD | 1.54% |
Description: PVAL Putnam Focused Large Cap November 08, 2025
The Putnam Focused Large-Cap Value ETF (NYSE ARCA:PVAL) seeks exposure to U.S. large-cap value equities, allocating at least 80 % of net assets to companies comparable in size to the Russell 1000 Value Index, while retaining flexibility to add midsize stocks. Its stated objective is to capture capital appreciation and/or current income from undervalued firms that the manager believes have upside potential.
Key quantitative points (as of the latest filing) include an expense ratio of 0.45 % and a trailing-12-month dividend yield around 2.1 %, modestly above the S&P 500 average. The fund’s top ten holdings are concentrated in financials, consumer staples and health care-sectors historically less sensitive to cyclical interest-rate swings, which is relevant given the current Federal Reserve tightening cycle. Compared with the broader large-value universe, PVAL’s turnover rate (≈30 % annually) suggests a relatively active positioning strategy, potentially allowing it to capitalize on short-term mispricings while maintaining a core value tilt.
Given the ongoing debate over the persistence of value premiums in a low-inflation, high-growth environment, a deeper dive into PVAL’s sector weightings and its overlap with the Russell 1000 Value Index could clarify whether its active tilt adds measurable alpha; you might find ValueRay’s analytical tools useful for that next step.
PVAL ETF Overview
| Market Cap in USD | 5,721m |
| Category | Large Value |
| TER | 0.56% |
| IPO / Inception | 2021-05-25 |
| Return 12m vs S&P 500 | -1.19% |
| Analyst Rating | - |
PVAL Dividends
| Metric | Value |
|---|---|
| Dividend Yield | 1.16% |
| Yield on Cost 5y | 2.08% |
| Yield CAGR 5y | 55.67% |
| Payout Consistency | 100.0% |
| Payout Ratio | - |
PVAL Growth Ratios
| Metric | Value |
|---|---|
| CAGR 3y | 17.20% |
| CAGR/Max DD Calmar Ratio | 1.12 |
| CAGR/Mean DD Pain Ratio | 7.35 |
| Current Volume | 1233.4k |
| Average Volume | 1111.7k |
What is the price of PVAL shares?
Over the past week, the price has changed by -2.64%, over one month by +0.79%, over three months by +4.58% and over the past year by +12.27%.
Is PVAL a buy, sell or hold?
What are the forecasts/targets for the PVAL price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 49.7 | 15.3% |
PVAL Fundamental Data Overview November 19, 2025
Beta = 0.93
Revenue TTM = 0.0 USD
EBIT TTM = 0.0 USD
EBITDA TTM = 0.0 USD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = unknown
Enterprise Value = 5.72b USD (5.72b + (null Debt) - (null CCE))
Interest Coverage Ratio = unknown (Ebit TTM 0.0 / Interest Expense TTM 0.0)
FCF Yield = 0.0% (FCF TTM 0.0 / Enterprise Value 5.72b)
FCF Margin = unknown (Revenue TTM is 0 or missing)
Net Margin = unknown
Gross Margin = unknown ((Revenue TTM 0.0 - Cost of Revenue TTM 0.0) / Revenue TTM)
Tobins Q-Ratio = unknown (Enterprise Value 5.72b / Total Assets none)
Interest Expense / Debt = unknown (Interest Expense 0.0 / Debt none)
Taxrate = 21.0% (US default 21%)
NOPAT = 0.0 (EBIT 0.0 * (1 - 21.00%))
Current Ratio = unknown (Total Current Assets none / Total Current Liabilities none)
Debt / Equity = unknown (Debt none)
Debt / EBITDA = unknown (Net Debt none / EBITDA 0.0)
Debt / FCF = unknown (Net Debt none / FCF TTM 0.0)
Total Stockholder Equity = 0.0 (from calculated bookValueOfEquity)
RoA = unknown (Net Income 0.0 / Total Assets none)
RoE = unknown (Net Income TTM 0.0 / Total Stockholder Equity 0.0)
RoCE = unknown (EBIT 0.0 / Capital Employed )
RoIC = unknown (NOPAT 0.0, Invested Capital 0.0, EBIT 0.0)
WACC = 8.83% (E(5.72b)/V(5.72b) * Re(8.83%) + (debt-free company))
Discount Rate = 8.83% (= CAPM, Blume Beta Adj.)
Fair Price DCF = unknown (Cash Flow 0.0)
Additional Sources for PVAL ETF
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle